ProPharma announces the appointment of Bryan Katz as new Chief Strategy Officer (CSO) / Head of Corporate Development
ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the expansion of the senior leadership team to include Bryan Katz as the new Chief Strategy Officer (CSO) / Head...
ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company
Chicago, IL, September 1, 2022 -- ProPharma Group (PPG), the leading global provider of regulatory, clinical and quality services for the life sciences industry, announces the acquisition of Kateric...
ProPharma Group Announces the Acquisition of Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...